Prescription drug · NDA
Lidocaine Hydrochloride and Dextrose (Lidocaine hydrochloride) NDC 0338-0411
Lidocaine hydrochloride 8 mg/mL · Injection, Solution · Intravenous · Baxter Healthcare Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0338-0411-02 | 00338041102 | 24 BAG in 1 CARTON (0338-0411-02) / 250 mL in 1 BAGMarketed from Apr 22, 1981 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lidocaine Hydrochloride and Dextrose
- Generic name (nonproprietary)
- lidocaine hydrochloride
- Active ingredients
- Lidocaine hydrochloride — 8 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Baxter Healthcare CorporationNDC labeler code 0338
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 018461
- Marketing start
- Listing expires
- Other FDA classes
- Amides (Chemical structure)Local Anesthesia (Physiologic effect)
- Identifiers
- Product ID 0338-0411_9e9121a0-25dd-46ba-a2b7-6f71fc3ff9cdSPL ID 9e9121a0-25dd-46ba-a2b7-6f71fc3ff9cdSPL set ID f21512ea-c7c3-4766-b976-b2c0b5616bf0RxCUI 1737723, 1737742, 1737744UNII V13007Z41A
- Pharmacologic class
- Amide Local Anesthetic; Antiarrhythmic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400338041102followed by a unit qualifier and the quantityPackage 00338-0411-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Lidocaine hydrochloride administered intravenously is specifically indicated in the acute management of (1) ventricular arrhythmias occurring during cardiac manipulations, such as cardiac surgery and (2) life-threatening arrhythmias which are ventricular in origin, such as occur during acute myocardial infarction.
Excerpt only. Read the full label for complete information.
About NDC 0338-0411
- What is NDC 0338-0411?
- 0338-0411 is the product NDC for Lidocaine Hydrochloride and Dextrose, Lidocaine hydrochloride 8 mg/mL injection, solution, listed with the FDA by Baxter Healthcare Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lidocaine Hydrochloride and Dextrose (Lidocaine Hydrochloride).
- What is the active ingredient?
- Lidocaine hydrochloride.
- Who is the labeler?
- Baxter Healthcare Corporation, NDC labeler code 0338. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lidocaine Hydrochloride and Dextrose?
- 5 other product NDCs are listed under this name. See all Lidocaine Hydrochloride and Dextrose NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Lidocaine Hydrochloride and Dextrose products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Lidocaine Hydrochloride and Dextroselidocaine hydrochloride anhydrous and dextrose monohydrate | Lidocaine hydrochloride anhydrous .4 g/100mL; Dextrose monohydrate 5 g/100mL | Injection, SolutionIntravenous | B. Braun Medical Inc. | 0264-9594 | 00264-9594-1000264-9594-20 |
| Lidocaine Hydrochloride and Dextroselidocaine hydrochloride anhydrous and dextrose monohydrate | Lidocaine hydrochloride anhydrous .8 g/100mL; Dextrose monohydrate 5 g/100mL | Injection, SolutionIntravenous | B. Braun Medical Inc. | 0264-9598 | 00264-9598-20 |
| Lidocaine Hydrochloride and Dextroselidocaine hydrochloride anhydrous and dextrose monohydrate | Lidocaine hydrochloride anhydrous .4 g/100mL; Dextrose monohydrate 5 g/100mL | Injection, SolutionIntravenous | ProPharma Distribution | 84549-594 | 84549-0594-20 |
| Lidocaine Hydrochloride and Dextroselidocaine hydrochloride | Lidocaine hydrochloride 4 mg/mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | 0338-0409 | 00338-0409-03 |
| Lidocaine Hydrochloride And Dextrose | Lidocaine hydrochloride 8 mg/mL | Injection, SolutionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1657 | 51662-1657-01 |
Other NDCs under NDA 018461
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lidocaine Hydrochloride and Dextroselidocaine hydrochloride | Lidocaine hydrochloride 4 mg/mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | 0338-0409 |
| Lidocaine Hydrochloride And Dextrose | Lidocaine hydrochloride 8 mg/mL | Injection, SolutionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1657 |